BMGL - Basel Medical Group Ltd


0.62
0.000   0.016%

Share volume: 45,177
Last Updated: 04-22-2026
Healthcare/Services – Health: 0.01%

PREVIOUS CLOSE
CHG
CHG%

$0.62
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
25%
Profitability 18%
Dept financing 0%
Liquidity 0%
Performance 45%
Performance
5 Days
-0.39%
1 Month
-10.16%
3 Months
-22.49%
6 Months
-60.51%
1 Year
-85.91%
2 Year
-84.84%
Key data
Stock price
$0.62
P/E Ratio 
N/A
DAY RANGE
$0.60 - $0.64
EPS 
N/A
52 WEEK RANGE
$0.49 - $9.40
52 WEEK CHANGE
-$86.03
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$23,591
AVERAGE 30 VOLUME 
$17,248
Company detail
CEO: Raymond Wai Man Cheung
Region: US
Website: baselmedical.com
Employees: 36
IPO year: 2025
Issue type:
Market: XNAS
Industry: Healthcare/Services – Health
Sector: Services

Basel Medical transcends the role of a conventional healthcare provider. We strive for excellence in medical services and aim to serve as a beacon of hope for patients across Singapore and Southeast Asia. Our principal executive offices are located in Singapore.

Recent news